The 3D screen printing technology of Laxxon Medical Corp. provides pharmaceutical companies with new, previously unknown possibilities for optimized and innovative drug delivery systems (DDS) for their product development and production processes.
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany
+49 361 · 7447-601 | info@bm-t.de
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany | +49 361·7447-601 | info@bm-t.de
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany
+49 361 · 7447-601 | info@bm-t.de
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany | +49 361·7447-601 | info@bm-t.de
Location: United States, New York
Investors 1
| Date | Name | Website |
| 01.02.2022 | bm-t betei... | bm-t.de |
Mentions in press and media 5
| Date | Title | Description |
| 02.02.2023 | Laxxon Medical to Participate in the BIO CEO & Investor Conference | NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Laxxon Medical, a pharma-technology company pioneering innovative 3D screen printed pharmaceutical solutions, announced today their participation in the BIO CEO & Investor Conference taking... |
| 24.07.2022 | Triastek and Eli Lilly partner to 3D print gastrointestinal drugs | Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals company Eli Lilly to research and develop 3D printed oral drugs for the gastrointestinal tract. Specifically, the project will leverage Triastek’... |
| 10.03.2022 | Evonik invests in Laxxon Medical for mass production of 3D printed pharmaceuticals | The venture capital arm of German chemicals firm Evonik has invested in Nevada-based 3D printed pharmaceutical firm Laxxon Medical to bring the mass production of 3D printed tablets closer to reality. The firms are partnering to fabricate n... |
| 10.01.2022 | Erste Kotierung am KMU-Segment der Schweizer Börse | |
| - | Settlement of the Swiss company Laxxon: 3D-printed medicines “Made in Jena” in the future | Laxxon optimises drug delivery thanks to a patented, innovative 3D screen printing process The technology company Laxxon Medical GmbH is settling in Jena and will in future develop and manufacture innovative medicines here on t... |